News

YFM Equity Partners announced in February a £12.35m investment in Audiological Science Ltd, a leading independent audiology provider which currently works with nine NHS BSW Integrated Care Board (ICBs), delivering high-quality hearing care in community settings across the UK.Candesic is ...

Read more

Baird Capital, global private equity group, is investing in Newmarket Strategy, a fast-growing specialist healthcare, medtech and life sciences consultancy specialising in market access.Candesic is pleased to have provided commercial due diligence to Baird Capital. The Candesic team, was led by ...

Read more

Leading cancer care provider GenesisCare UK has secured refinancing of up to £140 million, provided by Pemberton Asset Management, a leading private credit manager in Europe, and Barclays.GenesisCare UK is the UK's leading independent specialist cancer care provider and currently operates 14 ...

Read more

The London Clinic, the UK’s largest independent charitable hospital, and Northwestern Medicine, a leading U.S.-based academic healthcare organisation, announce a groundbreaking international collaboration. The agreement will accelerate The London Clinic’s infrastructure improvements and ...

Read more

Parkway Life Real Estate Investment Trust (PLife REIT), one of Asia’s largest listed healthcare REITs, has made its maiden acquisition in Europe from Domusvi, one of Europe’s largest nursing and retirement home providers, with the acquisition of 11 nursing homes in a sale and leaseback ...

Read more

Global private equity healthcare specialist ARCHIMED has acquired FIM Medical, a leader in the vision, audio & respiratory medical devices market. Candesic provided ARCHIMED with commercial due diligence. The Candesic team, was led by Senior Partner Marc Kitten and supervised by Associate ...

Read more

HealthNet Homecare, one of the UK’s largest clinical homecare providers, received investment from private equity firm CBPE Capital. Candesic was proud to provide HealthNet Homecare with vendor commercial due diligence. The Candesic team was led by Managing partner Dr Leonid Shapiro and ...

Read more

Mallinckrodt Pharmaceuticals has agreed to sell Therakos, the world leader in extracorporeal photopheresis systems (ECP), kits and drugs to leading global private markets manager CVC for $925 million.The Candesic team, led by Managing Partner Dr Leonid Shapiro and supervised by Principal Floris ...

Read more

Private equity investor LDC, part of Lloyds Banking Group, is investing in Dublin-based healthcare equipment and service provider Medray Imaging Systems.The Candesic team, led by Managing Partner Dr Leonid Shapiro and supervised by Engagement Manager Fabio Ruffinoni provided commercial due ...

Read more

Candesic provided commercial due diligence to the investors providing $80m of growth capital to pioneering AI drug discovery company CytoReason. CytoReason offers life sciences companies AI-enabled drug discovery tools to gather data-driven and molecular-level insights to improve success in ...

Read more